Kathryn Plante, MS

Kathryn (Kate) Plante, MS, is a Vice President who leads Fortrea’s global Market Access Consulting and HEOR group. In this role, she oversees several service areas: Integrated Evidence Planning, Real-world Evidence & Analytics, Value Demonstration, Health Economics & HTA, Reimbursement Strategy & Payer Insights (US and Europe), and Digital & Design Solutions. She specializes in the development and evaluation of evidence to support medical products across various stakeholders.

Kate has over 25 years of experience in observational study design, real-world data, data analytics, value communications, and health economics. She is well published with over 90 manuscripts and conference presentations in more than a dozen therapeutic areas. She recently co-authored two white papers focused on external control arms.

Before joining Fortrea (formerly Labcorp and Covance), Kate was a consultant at Price Waterhouse where she developed financial models and conducted fraud analysis using real-world trading data. She has also served as a statistical analyst supporting Phase I-3 clinical trials.

Kate earned an MS in Statistical Science from George Mason University, and a BS in Mathematics and a BS in Finance from the University of Vermont. She recently earned a certificate in Medical Writing from the University of Chicago Professional Education.